Qin Yangwen
Managing partner @ Neovision Capital
Qin Yangwen is a Series B investor at Neovision Capital focused on Biotechnology. Qin Yangwen
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Qin Yangwen invests in
Stages Qin Yangwen invests in
Countries Qin Yangwen invests in
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Maibang Bio
|
Maibang Bio is a cell culture medium product developer, focusing on the research and development of high-end chemically defined. | $15.7M / Series B / Apr 15, 2022 |
Co-Investors
About Neovision Capital
Neovision Capital was founded in 2015. Key founders are from Costone Capital, J.P. Morgan and so on. Leveraging its core team’s rich China-operational experiences, international resources, and business acumen, we are actually dedicated to both early and growth-stage investment in healthcare and TMT sector in China. In order to leverage our coreassets, we actively contribute expertise in essential services including branding, marketing, channel development, overseas expansion, human resources, and finance.
Neovision Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Liu Chuanwen
Managing Director
|
|||
|
Qin Yangwen
Managing partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Qin Yangwen invest in?
Qin Yangwen invests primarily in Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Qin Yangwen last invest?
The most recent investment recorded for Qin Yangwen closed in Apr 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
